Kovacs K, Stefaneanu L, Ezzat S, Smyth H S
Department of Pathology, St Michael's Hospital, Toronto, Ontario, Canada.
Arch Pathol Lab Med. 1994 May;118(5):562-5.
Pituitary adenoma developed in a 33-year-old male-to-female transsexual patient who was given estrogen, starting at 16 years of age; the pituitary adenoma was surgically removed and studied by light microscopy, immunocytochemistry, and in situ hybridization. The adenoma cells were immunoreactive for prolactin, and exhibited a strong signal for prolactin and estrogen receptor messenger RNAs and a weak signal for dopamine receptor messenger RNA. The question of whether the development of an adenoma was incidental or was the direct effect of estrogen or whether it was mediated via other mechanisms, such as activation of growth factors or oncogenes or inhibition of tumor-suppressing genes or other genetic abnormalities, remained unresolved. The present case, which, to our knowledge, is the first to describe structural findings of a pituitary adenoma in a transsexual patient who was given estrogen, reinforces the view that protracted stimulation may play a role in the genesis of endocrine tumors.
一名33岁的男变女变性患者患有垂体腺瘤,该患者自16岁起开始使用雌激素;垂体腺瘤经手术切除,并通过光学显微镜、免疫细胞化学和原位杂交进行研究。腺瘤细胞对催乳素呈免疫反应,对催乳素和雌激素受体信使核糖核酸显示强信号,对多巴胺受体信使核糖核酸显示弱信号。腺瘤的发生是偶然的,还是雌激素的直接作用,抑或是通过其他机制介导的,如生长因子或癌基因的激活、肿瘤抑制基因的抑制或其他基因异常,这个问题仍未解决。据我们所知,本病例是首例描述接受雌激素治疗的变性患者垂体腺瘤结构发现的病例,这进一步支持了长期刺激可能在内分泌肿瘤发生中起作用的观点。